210 related articles for article (PubMed ID: 17987251)
41. APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure.
Bekris LM; Galloway NM; Montine TJ; Schellenberg GD; Yu CE
Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):409-417. PubMed ID: 19554612
[TBL] [Abstract][Full Text] [Related]
42. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele.
Riemenschneider M; Schwarz S; Wagenpfeil S; Diehl J; Müller U; Förstl H; Kurz A
Mol Psychiatry; 2002; 7(7):782-5. PubMed ID: 12192623
[TBL] [Abstract][Full Text] [Related]
43. Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population.
Kamino K; Nagasaka K; Imagawa M; Yamamoto H; Yoneda H; Ueki A; Kitamura S; Namekata K; Miki T; Ohta S
Biochem Biophys Res Commun; 2000 Jun; 273(1):192-6. PubMed ID: 10873585
[TBL] [Abstract][Full Text] [Related]
44. Association of complement factor H Y402H gene polymorphism with Alzheimer's disease.
Zetterberg M; Landgren S; Andersson ME; Palmér MS; Gustafson DR; Skoog I; Minthon L; Thelle DS; Wallin A; Bogdanovic N; Andreasen N; Blennow K; Zetterberg H
Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):720-6. PubMed ID: 18163432
[TBL] [Abstract][Full Text] [Related]
45. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease.
Bratosiewicz-Wasik J; Liberski PP; Peplonska B; Styczynska M; Smolen-Dzirba J; Cycon M; Wasik TJ
Neurosci Lett; 2018 Sep; 684():86-90. PubMed ID: 29990559
[TBL] [Abstract][Full Text] [Related]
46. Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease.
Wiebusch H; Poirier J; Sévigny P; Schappert K
Hum Genet; 1999 Feb; 104(2):158-63. PubMed ID: 10190327
[TBL] [Abstract][Full Text] [Related]
47. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.
Lambert JC; Araria-Goumidi L; Myllykangas L; Ellis C; Wang JC; Bullido MJ; Harris JM; Artiga MJ; Hernandez D; Kwon JM; Frigard B; Petersen RC; Cumming AM; Pasquier F; Sastre I; Tienari PJ; Frank A; Sulkava R; Morris JC; St Clair D; Mann DM; Wavrant-DeVrièze F; Ezquerra-Trabalon M; Amouyel P; Hardy J; Haltia M; Valdivieso F; Goate AM; Pérez-Tur J; Lendon CL; Chartier-Harlin MC
Neurology; 2002 Jul; 59(1):59-66. PubMed ID: 12105308
[TBL] [Abstract][Full Text] [Related]
48. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
[TBL] [Abstract][Full Text] [Related]
49. An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.
Lescai F; Chiamenti AM; Codemo A; Pirazzini C; D'Agostino G; Ruaro C; Ghidoni R; Benussi L; Galimberti D; Esposito F; Marchegiani F; Cardelli M; Olivieri F; Nacmias B; Sorbi S; Tagliavini F; Albani D; Martinelli Boneschi F; Binetti G; Santoro A; Forloni G; Scarpini E; Crepaldi G; Gabelli C; Franceschi C
J Alzheimers Dis; 2011; 24(2):235-45. PubMed ID: 21263195
[TBL] [Abstract][Full Text] [Related]
50. Association of alpha-2-macroglobulin deletion polymorphism with sporadic Alzheimer's disease in Koreans.
Jhoo JH; Kim KW; Lee DY; Lee KU; Lee JH; Kim SY; Youn JY; Youn JC; Woo JI
J Neurol Sci; 2001 Feb; 184(1):21-5. PubMed ID: 11231028
[TBL] [Abstract][Full Text] [Related]
51. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
Drigalenko E; Poduslo S; Elston R
Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
[TBL] [Abstract][Full Text] [Related]
52. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.
Lambert JC; Berr C; Pasquier F; Delacourte A; Frigard B; Cottel D; Pérez-Tur J; Mouroux V; Mohr M; Cécyre D; Galasko D; Lendon C; Poirier J; Hardy J; Mann D; Amouyel P; Chartier-Harlin MC
Hum Mol Genet; 1998 Sep; 7(9):1511-6. PubMed ID: 9700208
[TBL] [Abstract][Full Text] [Related]
53. Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease.
Carrieri G; Bonafè M; De Luca M; Rose G; Varcasia O; Bruni A; Maletta R; Nacmias B; Sorbi S; Corsonello F; Feraco E; Andreev KF; Yashin AI; Franceschi C; De Benedictis G
Hum Genet; 2001 Mar; 108(3):194-8. PubMed ID: 11354629
[TBL] [Abstract][Full Text] [Related]
54. Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease.
Wang PN; Liu HC; Liu TY; Chu A; Hong CJ; Lin KN; Chi CW
Dement Geriatr Cogn Disord; 2005; 19(2-3):120-5. PubMed ID: 15591802
[TBL] [Abstract][Full Text] [Related]
55. Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.
Nicodemus KK; Stenger JE; Schmechel DE; Welsh-Bohmer KA; Saunders AM; Roses AD; Gilbert JR; Vance JM; Haines JL; Pericak-Vance MA; Martin ER
Neurogenetics; 2004 Dec; 5(4):201-8. PubMed ID: 15455263
[TBL] [Abstract][Full Text] [Related]
56. TOMM40 polymorphisms in Italian Alzheimer's disease and frontotemporal dementia patients.
Bagnoli S; Piaceri I; Tedde A; Bessi V; Bracco L; Sorbi S; Nacmias B
Neurol Sci; 2013 Jun; 34(6):995-8. PubMed ID: 23546992
[TBL] [Abstract][Full Text] [Related]
57. Risk of Alzheimer disease with the epsilon4 allele for apolipoprotein E in a population-based study of men aged 62-73 years.
Breitner JC; Jarvik GP; Plassman BL; Saunders AM; Welsh KA
Alzheimer Dis Assoc Disord; 1998 Mar; 12(1):40-4. PubMed ID: 9539409
[TBL] [Abstract][Full Text] [Related]
58. Brain APOE expression quantitative trait loci-based association study identified one susceptibility locus for Alzheimer's disease by interacting with APOE ε4.
Zhang A; Zhao Q; Xu D; Jiang S
Sci Rep; 2018 May; 8(1):8068. PubMed ID: 29795290
[TBL] [Abstract][Full Text] [Related]
59. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.
Laws SM; Hone E; Gandy S; Martins RN
J Neurochem; 2003 Mar; 84(6):1215-36. PubMed ID: 12614323
[TBL] [Abstract][Full Text] [Related]
60. Polymorphisms of the neurotrophic factor-3 (NTF-3) in Alzheimer's disease: rs6332 associated with onset time and rs6489630 T allele exhibited a protective role.
Liu M; Huo YR; Wang J; Liu S; Liu S; Wang C; Wang J; Ji Y
J Neurogenet; 2015; 29(4):183-7. PubMed ID: 26814132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
